Ftse Mib
37.038,71
-0,22%
DAX
21.914,26
0,01%
S&P 500
6.083,57
0,36%
NASDAQ
19.791,99
0,51%
Bitcoin
97.378,13
0,83%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Kiniksa Pharmaceuticals International PLC (KNSA) Kiniksa Pharmaceuticals International PLC (KNSA) Notizie

Kiniksa Pharmaceuticals International PLC

KNSA
20,29
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 11:47:53
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/1/202522:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202523:27EDGAR2Form 144 - Report of proposed sale of securities
13/1/202513:34EDGAR2Form 8-K - Current report
13/1/202513:30GLOBEKiniksa Pharmaceuticals Reports Preliminary 2024 Net Product..
06/1/202522:01GLOBEKiniksa Pharmaceuticals to Present at 43rd Annual J.P...
18/12/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202423:17EDGAR2Form 144 - Report of proposed sale of securities
10/12/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202423:25EDGAR2Form 144 - Report of proposed sale of securities
26/11/202422:01GLOBEKiniksa Pharmaceuticals to Present at 7th Annual Evercore..
20/11/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202423:50EDGAR2Form 144 - Report of proposed sale of securities
14/11/202422:32EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202422:15EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202422:01GLOBEKiniksa Pharmaceuticals to Present at Jefferies London..
08/11/202423:31EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
29/10/202421:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/10/202412:31EDGAR2Form 8-K - Current report
29/10/202412:30GLOBEKiniksa Pharmaceuticals Reports Third Quarter 2024 Financial..
28/10/202413:00GLOBEKiniksa Pharmaceuticals Partners with GRAMMY® Award-Winning..
22/10/202422:01GLOBEKiniksa Pharmaceuticals to Report Third Quarter 2024..
17/10/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/10/202422:57EDGAR2Form 144 - Report of proposed sale of securities
08/10/202423:08EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/10/202414:00GLOBENHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa..
25/9/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202423:02EDGAR2Form 144 - Report of proposed sale of securities
05/9/202402:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202402:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202402:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202402:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202422:01GLOBEKiniksa Pharmaceuticals to Present at 2024 Wells Fargo..
23/7/202422:39EDGAR2Form 144 - Report of proposed sale of securities
23/7/202422:38EDGAR2Form 15-15D/A - Suspension of duty to report [Section 13 and..
23/7/202422:38EDGAR2Form 144 - Report of proposed sale of securities
23/7/202413:54EDGAR2Form 8-K - Current report
23/7/202413:30GLOBEKiniksa Pharmaceuticals Reports Second Quarter 2024..
16/7/202422:01GLOBEKiniksa Pharmaceuticals to Report Second Quarter 2024..
09/7/202414:00GLOBEKiniksa Pharmaceuticals Commences Enrollment in Abiprubart..
24/6/202414:00GLOBEKiniksa Pharmaceuticals Partners with NHL Hall-of-Famer..
17/6/202414:30GLOBEKiniksa Pharmaceuticals Sponsors American Heart..
14/6/202422:27EDGAR2Form 8-K - Current report
05/6/202422:27EDGAR2Form 8-K - Current report
04/6/202422:01GLOBEKiniksa Pharmaceuticals to Present at Goldman Sachs 45th..
29/5/202423:19EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/5/202422:01GLOBEKiniksa Pharmaceuticals to Present at Bank of America..
23/4/202413:30GLOBEKiniksa Pharmaceuticals Reports First Quarter 2024 Financial..
16/4/202422:01GLOBEKiniksa Pharmaceuticals to Report First Quarter 2024..
02/4/202413:30GLOBEKiniksa Pharmaceuticals Announces Development Indication for..
Apertura: Min: Max:
Chiusura: 20,29

La tua Cronologia

NASDAQ
KNSA
Kiniksa Pharmaceuticals
BOV
K1SS34Q
Kohl`s
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci